1 / 8

NSAIDs: practices and concerns of pediatric subspecialists

NSAIDs: practices and concerns of pediatric subspecialists. Deborah M. Levy MD MS, Assistant Clinical Professor; Lisa F. Imundo MD, Assistant Clinical Professor, Columbia University Medical Center Poster presentation at ACR 2006 ( Arthritis Rheum 2006:54:S170)

francine
Download Presentation

NSAIDs: practices and concerns of pediatric subspecialists

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. NSAIDs: practices and concerns of pediatric subspecialists • Deborah M. Levy MD MS, Assistant Clinical Professor; Lisa F. Imundo MD, Assistant Clinical Professor, Columbia University Medical Center • Poster presentation at ACR 2006 (Arthritis Rheum 2006:54:S170) • Presented by Brandt Groh MD, Associate Professor, Penn State Children’s Hospital • Supported by an independent research grant from Pfizer, Inc.

  2. NSAIDs: practices and concerns of pediatric subspecialists: Methods Internet-based survey of US/Canadian physicians (338 respondents/1289 invitations) May 2005 • 165 pediatricians • 99 pediatric rheumatologists • 42 pediatric orthopedists • 24 pediatric surgeons

  3. NSAID prescribing frequency for specific indications grey = never green = rarely (>1x/yr) red = occasionally(>1x/mo) blue = frequently (>1x/wk)

  4. Side effects reported >1x/month by pediatric rheumatologists

  5. Prescribing habits by specialty 164/330 (50%) of physicians surveyed NEVER prescribe COX-2s • 119/165 (72%) pediatricians (81 primary care physicians, 38 specialists) • 19/24 (79%) pediatric surgeons • 22/42 (52%) pediatric orthopedic surgeons • 4/99 (4%) pediatric rheumatologists

  6. Summary • Traditional NSAID and COX-2 use perceived as safe by most pediatric physicians • Few non-rheumatologists prescribe COX-2 specific NSAIDs for their pediatric patients • Fewer side effects reported with COX-2 specific NSAIDs • Barriers to prescribing COX-2 specific NSAIDs exist • No significant cardiac side effects noted in this limited sample

More Related